Brought to you by 
Sihuan Pharmaceutical grosses HK$5.75bn via its IPO
10 May 2011
Executive Summary
Sihuan Pharmaceutical Holdings Group Ltd., China's largest cardio-cerebral vascular drugs producer, has grossed HK$5.75bn ($738mm) through the initial public offering of 1.25bn shares at HK$4.60 each on the Hong Kong Stock Exchange. The shares sold at the top of the range, which began at HK3.88, and the financing was more than 100 times oversubscribed.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sihuan Pharmaceutical grosses HK$5.75bn via its IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice